Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process–Part 1
In campaign 1, 103.9 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-tartaric acid salt (4) was prepared in 3 stages from l-alaninamide·HCl. The Stage 2 reaction, the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using H2, Pd/C, and THF as solvent, proved to be nonrobust. Ahead of campaign 2, the Stage 2 and 3 processes were redeveloped to provide a higher yielding and more robust set of reaction conditions. The key change was to conduct the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using NaBH4 in MeOH as solvent while maintaining a constant pH (pH = 8.5) by the addition of acetic acid. In campaign 2, (S)-2-(N-benzyl-N-methylamino)-1-propanamine was isolated as the d-mandelic acid salt. A total of 373 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-mandelic acid salt was produced in high yield and excellent quality. (S)-2-(N-Benzyl-N-methylamino)-1-propanamine is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.
Authors
- Jonathan C. Churchill (ORCID: https://orcid.org/0000-0003-4464-2702)
- Paul Leong
- James D. Firth (ORCID: https://orcid.org/0000-0003-2283-552X)
- John S Carey (ORCID: https://orcid.org/0000-0002-3654-0063)
- Sophie L. Berrell (ORCID: https://orcid.org/0000-0002-2959-7803)
Institutions
- The Priory Hospital (GB)
- Lonza (Switzerland) (CH)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acs.oprd.6c00296
- Citations
- 3
- Primary Topic
- Chemical Synthesis and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.78